Citius Oncology, Inc. CTOR Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s accounts payable?
- Citius Oncology, Inc. (CTOR) reported accounts payable of $8.88M in Q1 2026.
- How has Citius Oncology, Inc.'s accounts payable changed year-over-year?
- Citius Oncology, Inc.'s accounts payable increased by 15.7% year-over-year, from $7.68M to $8.88M.
- What is the long-term trend for Citius Oncology, Inc.'s accounts payable?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s accounts payable has grown at a 220.4% compound annual growth rate (CAGR), from $1.29M to $13.23M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.